Literature DB >> 15145787

Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression.

Peter Mancuso1, Claudio Canetti, Andrew Gottschalk, Patricia K Tithof, Marc Peters-Golden.   

Abstract

Leptin is a hormone secreted by adipocytes in correlation with total body fat mass. In addition to regulating energy homeostasis, leptin modulates immune functions such as macrophage phagocytosis and cytokine synthesis. Previously, we reported defective leukotriene synthesis in macrophages from leptin-deficient mice that could be restored with exogenous leptin. In the present study, we utilized macrophages from normal rodents to explore the mechanism by which leptin could enhance cellular leukotriene synthesis. Leptin pretreatment of either rat alveolar or murine peritoneal macrophages for 16 h dose dependently increased the synthesis of leukotriene B4 and cysteinyl leukotrienes in response to calcium ionophore or the particulate zymosan. Leptin also enhanced calcium ionophore-stimulated release of free arachidonic acid. Calcium-dependent and -independent arachidonoyl-selective phospholipase activities in macrophage lysates were likewise increased following leptin treatment. Immunoblot analysis of leptin-treated cells revealed that group IVC iPLA2 (cPLA2gamma) protein expression increased approximately 80%. These data demonstrate for the first time that phospholipase A2 activity and cPLA2gamma protein levels in alveolar macrophages represent targets for upregulation by leptin and provide previously unrecognized mechanisms by which this hormone can promote inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145787     DOI: 10.1152/ajplung.00010.2004

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  41 in total

Review 1.  Metabolic Syndrome and the Lung.

Authors:  Cynthia W Baffi; Lisa Wood; Daniel Winnica; Patrick J Strollo; Mark T Gladwin; Loretta G Que; Fernando Holguin
Journal:  Chest       Date:  2016-01-20       Impact factor: 9.410

Review 2.  Multiple roles of phospholipase A2 during lung infection and inflammation.

Authors:  Bryan P Hurley; Beth A McCormick
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

Review 3.  Role of obesity and adipose tissue-derived cytokine leptin during Clostridium difficile infection.

Authors:  Rajat Madan; William A Petri
Journal:  Anaerobe       Date:  2015-01-29       Impact factor: 3.331

4.  Differential effects of energy balance on experimentally-induced colitis.

Authors:  Sarah J McCaskey; Elizabeth A Rondini; Ingeborg M Langohr; Jenifer I Fenton
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

5.  The Role of Phospholipase A(2)-derived Mediators in Obesity.

Authors:  Marcia J Abbott; Tianyi Tang; Hei Sook Sul
Journal:  Drug Discov Today Dis Mech       Date:  2010

Review 6.  Innate immune activation in obesity.

Authors:  Carey N Lumeng
Journal:  Mol Aspects Med       Date:  2012-10-13

Review 7.  Obesity in asthma: approaches to treatment.

Authors:  Shyamala Pradeepan; Garth Garrison; Anne E Dixon
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 8.  Role of leptin in the activation of immune cells.

Authors:  Patricia Fernández-Riejos; Souad Najib; Jose Santos-Alvarez; Consuelo Martín-Romero; Antonio Pérez-Pérez; Carmen González-Yanes; Víctor Sánchez-Margalet
Journal:  Mediators Inflamm       Date:  2010-03-23       Impact factor: 4.711

Review 9.  Obesity and lung inflammation.

Authors:  Peter Mancuso
Journal:  J Appl Physiol (1985)       Date:  2009-10-29

10.  Effect of allergy and inflammation on eicosanoid gene expression in CFTR deficiency.

Authors:  Justin S Bickford; Christian Mueller; Kimberly J Newsom; Sarah J Barilovits; Dawn E Beachy; John D Herlihy; Benjamin Keeler; Terence R Flotte; Harry S Nick
Journal:  J Cyst Fibros       Date:  2012-09-15       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.